Thomas E. Polen serves as the Chairman of the Board, Chief Executive Officer, and President at Becton, Dickinson and Company (BD), a global medical technology company. Polen joined BD in 2002 and has held various leadership positions within the organization. Before his current role, he served as the President of BD's Medical Segment, where he was responsible for the strategic direction and operational performance of the segment, which includes medical surgical systems, diabetes care, and pharmaceutical systems. Under Polen's leadership, BD has seen significant growth and transformation. He has been instrumental in driving the company's innovation agenda, focusing on developing advanced medical technologies and solutions that improve patient care and outcomes. One of his notable achievements includes leading BD's acquisition of C.R. Bard, Inc. in 2017, a strategic move that expanded BD's portfolio and strengthened its position in the medical technology industry. Polen's strategic vision and commitment to excellence have been key factors in BD's success, positioning the company as a leader in the healthcare sector. As Chairman, CEO, and President, Polen is responsible for overseeing BD's overall strategy, operations, and financial performance. He works closely with the board of directors and executive team to ensure that BD continues to deliver value to its shareholders, customers, and employees. Polen's leadership style is characterized by a focus on collaboration, innovation, and a deep commitment to advancing healthcare worldwide. His contributions to BD and the medical technology industry have earned him recognition as a respected leader in the field.